Cholestasis-Associated Pulmonary Inflammation, Oxidative Stress, and Tissue Fibrosis: The Protective Role of the Biogenic Amine Agmatine

• Published in: Pharmacology Vol. 108; no. 4; p. 379
• Main Authors: Ommati, Mohammad Mehdi, Niknahad, Hossein, Najibi, Asma, Arjmand, Abdollah, Alidaee, Sepideh, Mazloomi, Sahra, Ahmadi, Parinaz, Ghiasvand, Alireza, Javadi, Maral, Yazdani, Jamal, Sabouri, Samira, Rezaei, Heresh, Azarpira, Negar, Heidari, Reza
• Format: Journal Article
• Language: English
• Published: Switzerland 01-07-2023
• Subjects: Agmatine - metabolism; Agmatine - pharmacology; Agmatine - therapeutic use; Animals; Biogenic Amines - metabolism; Biogenic Amines - pharmacology; Biomarkers - metabolism; Cholestasis - complications; Cholestasis - drug therapy; Cholestasis - metabolism; Cytokines - metabolism; Fibrosis; Humans; Liver; Lung Injury; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Pneumonia - complications; Pneumonia - drug therapy; Pneumonia - prevention & control; Bile acid; Cytokine; Liver-lung axis; Pharmacotherapy; Pulmonary damage; Inflammation; Agmatine
• ISSN: 1423-0313
• DOI: 10.1159/000530307

Cholestasis is the stoppage of bile flow, leading to the accumulation of potentially cytotoxic bile components in the liver. These cytotoxic molecules affect many organs. Cholestasis-induced lung injury is a severe complication that could lead to tissue fibrosis and respiratory distress. Substantial evidence indicates the role of oxidative stress and inflammatory response in the pathogenesis of cholestasis-associated pulmonary damage. Agmatine (AGM; 1-amino-4-guanidinobutane) is a biogenic amine endogenously synthesized in the human body. This amine provides potent anti-inflammatory and antioxidant properties.
In the current study, a series (six C57BL/6J male mice/group) of bile duct-ligated (BDL) animals were monitored at scheduled intervals (7, 14, and 28 days after the BDL operation) to ensure inflammatory response in their lung tissue (by analyzing their bronchoalveolar lavage fluid [BALF]). It was found that the level of inflammatory cells, pro-inflammatory cytokines, and IgG in the BALF reached their maximum level on day 28 after the BDL surgery. Therefore, other research groups were selected as follows: 1) Sham-operated (2.5 mL/kg normal saline, i.p., for 28 consecutive days), 2) BDL, 3) BDL + AGM (1 mg/kg/day, i.p., for 28 consecutive days), and 4) BDL + AGM (10 mg/kg/day, i.p., for 28 consecutive days). Then, the BALF was monitored at scheduled time intervals (7, 14, and 28 days post-BDL).
It was found that pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β), bile acids, bilirubin, and inflammatory cells (monocytes, neutrophils, and lymphocytes) were significantly increased in the BALF of BDL mice. Moreover, biomarkers of oxidative stress were significantly increased in the pulmonary tissue of cholestatic animals. Lung tissue histopathological changes, tissue collagen deposition, and increased TGF-β were also detected. It was found that AGM significantly ameliorated cholestasis-induced lung injury.
The effects of AGM on inflammatory indicators, oxidative stress biomarkers, and tissue fibrosis seem to play a pivotal role in its protective properties.